Glutamate and dopamine in schizophrenia: An update for the 21st century

O Howes, R McCutcheon… - Journal of …, 2015 - journals.sagepub.com
The glutamate and dopamine hypotheses are leading theories of the pathoaetiology of
schizophrenia. Both were initially based on indirect evidence from pharmacological studies …

A review of reward processing and motivational impairment in schizophrenia

GP Strauss, JA Waltz, JM Gold - Schizophrenia bulletin, 2014 - academic.oup.com
This article reviews and synthesizes research on reward processing in schizophrenia, which
has begun to provide important insights into the cognitive and neural mechanisms …

[HTML][HTML] Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment

MJ Millan, K Fone, T Steckler, WP Horan - European …, 2014 - Elsevier
Schizophrenia is a complex and multifactorial disorder generally diagnosed in young adults
at the time of the first psychotic episode of delusions and hallucinations. These positive …

Ventral striatal activation during reward processing in psychosis: a neurofunctional meta-analysis

J Radua, A Schmidt, S Borgwardt, A Heinz… - JAMA …, 2015 - jamanetwork.com
Importance Abnormal reward processing is suggested to underlie the formation of psychotic
symptoms, likely driven by elevated ventral striatal (VS) dopamine levels. Functional …

An integrative perspective on the role of dopamine in schizophrenia

TV Maia, MJ Frank - Biological psychiatry, 2017 - Elsevier
We propose that schizophrenia involves a combination of decreased phasic dopamine
responses for relevant stimuli and increased spontaneous phasic dopamine release. Using …

The link between schizophrenia and substance use disorder: A unifying hypothesis

JY Khokhar, LL Dwiel, AM Henricks, WT Doucette… - Schizophrenia …, 2018 - Elsevier
Substance use disorders occur commonly in patients with schizophrenia and dramatically
worsen their overall clinical course. While the exact mechanisms contributing to substance …

The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs

AM Kring, DM Barch - European Neuropsychopharmacology, 2014 - Elsevier
A range of emotional and motivation impairments have long been clinically documented in
people with schizophrenia, and there has been a resurgence of interest in understanding …

Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia

DK Sarpal, DG Robinson, T Lencz, M Argyelan… - JAMA …, 2015 - jamanetwork.com
Importance Previous evidence has implicated corticostriatal abnormalities in the
pathophysiology of psychosis. Although the striatum is the primary target of all efficacious …

Neural substrates of reward anticipation and outcome in schizophrenia: a meta-analysis of fMRI findings in the monetary incentive delay task

J Zeng, J Yan, H Cao, Y Su, Y Song, Y Luo… - Translational …, 2022 - nature.com
Dysfunction of the mesocorticolimbic dopaminergic reward system is a core feature of
schizophrenia (SZ), yet its precise contributions to different stages of reward processing and …

A transdiagnostic review of negative symptom phenomenology and etiology

GP Strauss, AS Cohen - Schizophrenia bulletin, 2017 - academic.oup.com
In the DSM5, negative symptoms are 1 of the 5 core dimensions of psychopathology
evaluated for schizophrenia. However, negative symptoms are not pathognomonic—they …